Disclosed is a composition for treating a patient wherein the composition comprises: (a) at least 50%wt honey or a honey analogue(b) 2-15%wt of a natural based short chain fatty alcohol with non-ionic surfactant properties selected from fatty alcohols with a tail comprising 6 to 10 carbon atoms (c) 1 to 50%wt of at least one natural based topical carrier or vehicle with a set point of 45 Deg C or less selected from the group consisting of: a fatty ester, synthetic wax, beeswax, vegetal wax, mineral wax, a spermaceti wax constituent, carnauba wax and jojoba liquid wax,wherein the composition has been subjected to a sterilisation effective dosage of radiation and is storage stable for a time period of at least 24 hours at 40 Deg C. Also disclosed is an irradiated gelatinous composition consisting of: (a) 70-90%wt honey (b) 2-15%wt myristyl myristate and (c) 2-10%wt caprylyl capryl glucoside.
